Fulgent Genetics is a diagnostics company offering genetic and molecular testing services, including inherited-disease, oncology, and infectious-disease testing, and is developing therapeutic drug candidates.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Paul Tudor Jones / Tudor | 61 | Added +221% | 262,344 | $5,776,815 | 0.0% |
| Ancora | 42 | Holds (flat) | 500 | $11,010 | 0.0% |
| Steve Cohen / Point72 | 75 | Trimmed -74% | 54,318 | $1,196,082 | 0.0% |
| Louis Bacon / Moore | 52 | Trimmed -8% | 44,390 | $977,468 | 0.0% |
| Filed | Form | Activist | % of class | Conviction | |
|---|---|---|---|---|---|
| 2026-03-31 | SCHEDULE 13D/A | Hsieh Ming | 30.7% | Med | filing |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.